Ignite Creation Date:
2025-12-25 @ 12:27 AM
Ignite Modification Date:
2026-02-24 @ 10:20 PM
Study NCT ID:
NCT01914367
Status:
COMPLETED
Last Update Posted:
2022-12-09
First Post:
2013-06-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of the Molecular Mechanisms Underlying the Cross-neutralizing Capacity of AS04-adjuvanted HPV Vaccine (Cervarix®) in Comparison With the Aluminiumhydroxyphosphate Sulphate Adjuvanted HPV Vaccine (Gardasil®)
Sponsor:
University Hospital, Ghent
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-06-25
Start Date Type:
ACTUAL
Primary Completion Date:
2015-09-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-09-23
Completion Date Type:
ACTUAL
First Submit Date:
2013-06-06
First Submit QC Date:
None
Study First Post Date:
2013-08-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-06
Last Update Post Date:
2022-12-09
Last Update Post Date Type:
ACTUAL